Ascletis Pharma Inc.
HKEX:1672.HK
1.51 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 5.045 | 5.045 | 23.253 | 23.253 | 7.936 | 7.936 | 19.109 | 19.109 | 20.164 | 20.164 | 18.275 | 18.275 | 1.584 | 1.584 | 15.917 | 15.917 | 49.02 | 49.02 | 37.702 | 37.702 | 25.6 | 25.6 | 64.064 | 51.062 | 13.301 | 13.301 | 13.3 | 13.301 |
| Cost of Revenue
| 0 | 0 | 11.36 | 11.36 | 3.943 | 3.943 | 32.466 | 32.466 | 6.926 | 6.926 | 0.703 | 0.703 | 19.555 | 19.555 | 28.164 | 28.164 | 8.743 | 8.743 | 14.717 | 14.717 | 9.864 | 9.864 | 4.791 | 4.791 | 2.798 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -6.315 | -6.315 | 19.31 | 19.31 | -24.53 | -24.53 | 12.184 | 12.184 | 19.461 | 19.461 | -1.28 | -1.28 | -26.581 | -26.581 | 7.175 | 7.175 | 34.304 | 34.304 | 27.838 | 27.838 | 20.809 | 20.809 | 61.266 | 51.062 | 13.301 | 13.301 | 13.3 | 13.301 |
| Gross Profit Ratio
| 0 | 0 | -1.252 | -1.252 | 0.83 | 0.83 | -3.091 | -3.091 | 0.638 | 0.638 | 0.965 | 0.965 | -0.07 | -0.07 | -16.786 | -16.786 | 0.451 | 0.451 | 0.7 | 0.7 | 0.738 | 0.738 | 0.813 | 0.813 | 0.956 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 66.191 | 66.191 | 62.262 | 62.262 | 46.129 | 46.129 | 74.144 | 74.144 | 59.407 | 59.407 | 69.647 | 69.647 | 37.013 | 37.013 | 28.682 | 28.682 | 25.868 | 25.868 | 30.897 | 30.897 | 32.085 | 32.085 | 41.861 | 41.861 | 36.916 | 22.815 | 37.125 | 37.125 | 29.503 | 10.572 |
| General & Administrative Expenses
| 20.678 | 20.678 | 44.843 | 44.843 | 12.974 | 12.974 | 8.615 | 8.615 | 8.985 | 8.985 | 3.935 | 3.935 | 11.039 | 11.039 | 9.59 | 9.59 | 11.333 | 11.333 | 10.541 | 10.541 | 13.941 | 13.941 | 18.991 | 18.991 | 30.655 | 15.717 | 12.85 | 12.85 | 8.051 | 3.015 |
| Selling & Marketing Expenses
| 0 | 0 | 0.179 | 0.179 | 0.372 | 0.372 | 3.261 | 3.261 | 5.232 | 5.232 | 5.693 | 5.693 | 4.744 | 4.744 | 4.792 | 4.792 | 8.887 | 8.887 | 28.104 | 28.104 | 22.146 | 22.146 | 27.531 | 27.531 | 3.571 | 0 | 0.356 | 0.356 | 0 | 0 |
| SG&A
| 20.678 | 20.678 | 44.664 | 44.664 | 13.346 | 13.346 | 11.876 | 11.876 | 14.216 | 14.216 | 9.627 | 9.627 | 15.783 | 15.783 | 14.381 | 14.381 | 20.22 | 20.22 | 38.394 | 38.394 | 36.338 | 36.338 | 47.24 | 47.24 | 34.226 | 15.717 | 13.206 | 13.206 | 8.051 | 3.015 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.121 | -1.8 | 0 | 0 | -5.517 | 0 |
| Operating Expenses
| 86.869 | 86.869 | 106.926 | 85.144 | 53.969 | 53.969 | 105.307 | 105.307 | 63.432 | 63.432 | 71.231 | 71.231 | 60.297 | 60.297 | 58.679 | 58.679 | 46.927 | 46.927 | 78.074 | 78.074 | 68.081 | 68.081 | 51.4 | 51.4 | 59.021 | 36.732 | 48.006 | 48.006 | 32.037 | 13.587 |
| Operating Income
| -86.869 | -86.869 | -113.241 | -114.057 | -40.416 | -40.416 | -111.863 | -111.863 | -62.446 | -62.446 | -59.677 | -59.677 | -55.558 | -55.558 | -76.716 | -76.716 | -47.745 | -47.745 | -56.557 | -56.557 | -48.178 | -48.178 | -72.978 | -72.978 | 9.166 | 14.591 | -37.03 | -37.03 | -18.565 | -1.819 |
| Operating Income Ratio
| 0 | 0 | -22.446 | -22.608 | -1.738 | -1.738 | -14.096 | -14.096 | -3.268 | -3.268 | -2.96 | -2.96 | -3.04 | -3.04 | -48.447 | -48.447 | -3 | -3 | -1.154 | -1.154 | -1.278 | -1.278 | -2.851 | -2.851 | 0.143 | 0.286 | -2.784 | -2.784 | -1.396 | -0.137 |
| Total Other Income Expenses Net
| 21.71 | 21.71 | 49.163 | 49.979 | 31.886 | 31.886 | -1.56 | -1.56 | 17.441 | 17.441 | 15.719 | 15.719 | -1.339 | -1.339 | -9.245 | -9.245 | 13.18 | 13.18 | 32.188 | 32.188 | 16.968 | 16.968 | 47.6 | 47.6 | 32.372 | -15.313 | 7.295 | 7.295 | -5.894 | 3.946 |
| Income Before Tax
| -65.159 | -65.159 | -64.078 | -64.078 | -8.28 | -8.28 | -113.423 | -113.423 | -43.999 | -43.999 | -44.095 | -44.095 | -55.414 | -55.414 | -78.888 | -78.888 | -25.733 | -25.733 | -24.369 | -24.369 | -23.616 | -23.616 | -20.692 | -20.692 | 22.496 | -0.983 | -29.735 | -29.735 | -24.631 | 3.66 |
| Income Before Tax Ratio
| 0 | 0 | -12.701 | -12.701 | -0.356 | -0.356 | -14.292 | -14.292 | -2.303 | -2.303 | -2.187 | -2.187 | -3.032 | -3.032 | -49.819 | -49.819 | -1.617 | -1.617 | -0.497 | -0.497 | -0.626 | -0.626 | -0.808 | -0.808 | 0.351 | -0.019 | -2.236 | -2.236 | -1.852 | 0.275 |
| Income Tax Expense
| 0 | -0.1 | -0.817 | 0 | 12.099 | 0 | 13.495 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.33 | -0.125 | 0.04 | 0.04 | -0.026 | 6.595 |
| Net Income
| -65.159 | -65.159 | -64.078 | -64.078 | -8.28 | -8.28 | -113.423 | -113.423 | -43.999 | -43.999 | -44.095 | -44.095 | -55.414 | -55.414 | -78.888 | -78.888 | -25.733 | -25.733 | -24.369 | -24.369 | -23.616 | -23.616 | -20.692 | -20.692 | 35.826 | -0.858 | -18.234 | -18.234 | -24.605 | -2.935 |
| Net Income Ratio
| 0 | 0 | -12.701 | -12.701 | -0.356 | -0.356 | -14.292 | -14.292 | -2.303 | -2.303 | -2.187 | -2.187 | -3.032 | -3.032 | -49.819 | -49.819 | -1.617 | -1.617 | -0.497 | -0.497 | -0.626 | -0.626 | -0.808 | -0.808 | 0.559 | -0.017 | -1.371 | -1.371 | -1.85 | -0.221 |
| EPS
| -0.064 | -0.064 | -0.06 | -0.06 | -0.008 | -0.008 | -0.1 | -0.1 | -0.041 | -0.041 | -0.04 | -0.04 | -0.051 | -0.051 | -0.076 | -0.076 | -0.025 | -0.025 | -0.023 | -0.023 | -0.022 | -0.022 | -0.023 | -0.023 | 0.032 | -0.001 | -0.05 | -0.05 | -0.022 | -0.003 |
| EPS Diluted
| -0.064 | -0.064 | -0.06 | -0.06 | -0.008 | -0.008 | -0.1 | -0.1 | -0.041 | -0.041 | -0.04 | -0.04 | -0.05 | -0.05 | -0.076 | -0.076 | -0.025 | -0.025 | -0.023 | -0.023 | -0.022 | -0.022 | -0.023 | -0.023 | 0.032 | -0.001 | -0.05 | -0.05 | -0.022 | -0.003 |
| EBITDA
| -82.956 | -82.956 | -110.826 | -110.826 | -36.622 | -36.622 | -105.737 | -105.737 | -55.507 | -55.507 | -53.663 | -53.663 | -48.755 | -48.755 | -70.638 | -70.638 | -42.043 | -42.043 | -51.599 | -51.599 | -43.271 | -43.271 | -68.725 | -68.725 | 10.947 | 16.155 | -35.521 | -35.521 | -17.236 | 0.666 |
| EBITDA Ratio
| 0 | 0 | -21.967 | -21.967 | -1.575 | -1.575 | -13.324 | -13.324 | -2.905 | -2.905 | -2.661 | -2.661 | -2.668 | -2.668 | -44.609 | -44.609 | -2.641 | -2.641 | -1.053 | -1.053 | -1.148 | -1.148 | -2.685 | -2.685 | 0.171 | 0.316 | -2.671 | -2.671 | -1.283 | -0.065 |